WESPAC Advisors SoCal’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

WESPAC Advisors SoCal’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,404	Closed	-$1.25M	–	79
2022 Q1	$1.25M	Buy	8,404 +140	+2%	+$20.7K	0.39%	47
2021 Q4	$1.25M	Sell	8,264 -2,144	-21%	-$347K	0.38%	43
2021 Q3	$1.69M	Buy	10,408 +200	+2%	+$34.2K	0.55%	43
2021 Q2	$1.76M	Buy	10,208 +290	+3%	+$47.9K	0.58%	40
2021 Q1	$1.59M	Buy	9,918 +7,177	+262%	+$1.23M	0.62%	37
2020 Q4	$460K	Sell	2,741 -279	-9%	-$45.3K	0.18%	61
2020 Q3	$494K	Buy	3,020 +180	+6%	+$29.4K	0.24%	53
2020 Q2	$492K	Buy	2,840 +465	+20%	+$73K	0.23%	53
2020 Q1	$361K	Buy	+2,375	New	+$338K	0.2%	52
2016 Q1	–	Sell	-6,265	Closed	-$708K	–	304
2015 Q4	$708K	Buy	+6,265	New	+$675K	0.47%	40

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

WESPAC Advisors SoCal's FBT Position: Q2 2022 in Review

WESPAC Advisors SoCal sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2022, closing a stake of 8,404 shares — an estimated $1.25M sold.

WESPAC Advisors SoCal first reported a position in FBT in Q4 2015 and held it in 10 quarters. The position peaked at $1.76M in Q2 2021. 224 funds tracked by Wall St. Rank hold FBT as of Q2 2022.

WESPAC Advisors SoCal reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2022 after selling out during the quarter.
WESPAC Advisors SoCal sold 8,404 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2022, an estimated $1.25M.
WESPAC Advisors SoCal first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2015 and held it in 10 quarters.
WESPAC Advisors SoCal's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.76M in Q2 2021.
224 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2022.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2022, filed 19 Jul 2022.